Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells

[1]  Ming-Tsan Lin,et al.  Cyr61/CTGF/Nov family proteins in gastric carcinogenesis. , 2014, World journal of gastroenterology.

[2]  H. Chung,et al.  Role of the tumor microenvironment in the pathogenesis of gastric carcinoma. , 2014, World journal of gastroenterology.

[3]  Hyung Gyun Kim,et al.  Antitumor efficacy of piperine in the treatment of human HER2-overexpressing breast cancer cells. , 2013, Food chemistry.

[4]  T. Guo,et al.  Mechanism of the inhibition of the STAT3 signaling pathway by EGCG. , 2013, Oncology reports.

[5]  Tuan-jie Li,et al.  Activation of STAT3 in Human Gastric Cancer Cells via Interleukin (IL)-6-Type Cytokine Signaling Correlates with Clinical Implications , 2013, PloS one.

[6]  H. Pan,et al.  Piperine inhibits the proliferation of human prostate cancer cells via induction of cell cycle arrest and autophagy. , 2013, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[7]  K. Koike,et al.  Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis , 2013, PloS one.

[8]  Yefeng Yin,et al.  The nuclear factor-κB correlates with increased expression of interleukin-6 and promotes progression of gastric carcinoma , 2012, Oncology reports.

[9]  Z. Duan,et al.  Interleukin-6 signaling pathway in targeted therapy for cancer. , 2012, Cancer treatment reviews.

[10]  Hyung Gyun Kim,et al.  Piperine inhibits PMA-induced cyclooxygenase-2 expression through downregulating NF-κB, C/EBP and AP-1 signaling pathways in murine macrophages. , 2012, Food and Chemical Toxicology.

[11]  M. Vincenti,et al.  Interleukin-1β mediates metalloproteinase-dependent renal cell carcinoma tumor cell invasion through the activation of CCAAT enhancer binding protein β , 2012, Cancer medicine.

[12]  H. Hermanns,et al.  Plasticity and cross-talk of interleukin 6-type cytokines. , 2012, Cytokine & growth factor reviews.

[13]  Christian Ehlting,et al.  The macrophage response towards LPS and its control through the p38(MAPK)-STAT3 axis. , 2012, Cellular signalling.

[14]  R. Uzzo,et al.  Co‐administration of piperine and docetaxel results in improved anti‐tumor efficacy via inhibition of CYP3A4 activity , 2012, The Prostate.

[15]  Qing-qing Wang,et al.  Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model , 2012, Acta Pharmacologica Sinica.

[16]  S. Dima,et al.  IL-6 and IL-11 as markers for tumor aggressiveness and prognosis in gastric adenocarcinoma patients without mutations in Gp130 subunits. , 2012, Journal of gastrointestinal and liver diseases : JGLD.

[17]  A. Yoshimura,et al.  IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. , 2011, International immunology.

[18]  Bon Soon Koo,et al.  Piperine ameliorates the severity of cerulein-induced acute pancreatitis by inhibiting the activation of mitogen activated protein kinases. , 2011, Biochemical and biophysical research communications.

[19]  Hyung Gyun Kim,et al.  Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKCα/ERK1/2-dependent matrix metalloproteinase-9 expression. , 2011, Toxicology letters.

[20]  B. Mroczko,et al.  [The role of interleukin-6 and C-reactive protein in gastric cancer]. , 2010, Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego.

[21]  Sung-Joo Park,et al.  Inhibition of lipopolysaccharide-induced inflammatory responses by piperine. , 2010, European journal of pharmacology.

[22]  Yan Liu,et al.  IL-6, a risk factor for hepatocellular carcinoma: FLLL32 inhibits IL-6-Induced STAT3 phosphorylation in human hepatocellular cancer cells , 2010, Cell cycle.

[23]  A. Jemal,et al.  Global Patterns of Cancer Incidence and Mortality Rates and Trends , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[24]  A. Saba,et al.  Capsaicin: a novel chemopreventive molecule and its underlying molecular mechanisms of action. , 2010, Indian journal of cancer.

[25]  G. Dontu,et al.  Targeting breast stem cells with the cancer preventive compounds curcumin and piperine , 2010, Breast Cancer Research and Treatment.

[26]  Min-Chan Kim,et al.  Expression of VEGF, EGFR, and IL-6 in Gastric Adenomas and Adenocarcinomas by Endoscopic Submucosal Dissection , 2010, Digestive Diseases and Sciences.

[27]  Hua Yu,et al.  IL-17 can promote tumor growth through an IL-6–Stat3 signaling pathway , 2009, The Journal of experimental medicine.

[28]  Byung Geun Kim,et al.  Clinical significances of preoperative serum interleukin-6 and C-reactive protein level in operable gastric cancer , 2009, BMC Cancer.

[29]  L. Samavati,et al.  STAT3 tyrosine phosphorylation is critical for interleukin 1 beta and interleukin-6 production in response to lipopolysaccharide and live bacteria. , 2009, Molecular immunology.

[30]  C. Cahill,et al.  Interleukin (IL) 1β Induction of IL-6 Is Mediated by a Novel Phosphatidylinositol 3-Kinase-dependent AKT/IκB Kinase α Pathway Targeting Activator Protein-1* , 2008, Journal of Biological Chemistry.

[31]  A. Boussioutas,et al.  Augmented gp130‐mediated cytokine signalling accompanies human gastric cancer progression , 2007, The Journal of pathology.

[32]  Y. Jeng,et al.  IL‐6 induces AGS gastric cancer cell invasion via activation of the c‐Src/RhoA/ROCK signaling pathway , 2007, International journal of cancer.

[33]  Amit Sharma,et al.  Piperine inhibits TNF-alpha induced adhesion of neutrophils to endothelial monolayer through suppression of NF-kappaB and IkappaB kinase activation. , 2007, European journal of pharmacology.

[34]  Y. Carmi,et al.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions , 2006, Cancer and Metastasis Reviews.

[35]  C. Cetrulo,et al.  Regulation of IL‐1‐induced selective IL‐6 release from human mast cells and inhibition by quercetin , 2006, British journal of pharmacology.

[36]  K. Selvendiran,et al.  In vivo effect of piperine on serum and tissue glycoprotein levels in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. , 2006, Pulmonary pharmacology & therapeutics.

[37]  B. Wung,et al.  Resveratrol suppresses IL-6-induced ICAM-1 gene expression in endothelial cells: effects on the inhibition of STAT3 phosphorylation. , 2005, Life sciences.

[38]  Tetsuo Sumi,et al.  Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: role of IL-6 as a prognostic factor , 2005, Gastric Cancer.

[39]  G. Kuttan,et al.  Piperine is a potent inhibitor of nuclear factor-κB (NF-κB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells , 2004 .

[40]  Hsiu‐Po Wang,et al.  Interleukin-6 Increases Vascular Endothelial Growth Factor and Angiogenesis in Gastric Carcinoma , 2004, Journal of Biomedical Science.

[41]  K. Kirkwood,et al.  p38 MAPK Regulates IL‐1β Induced IL‐6 Expression Through mRNA Stability in Osteoblasts , 2004, Immunological investigations.

[42]  G. Kuttan,et al.  Piperine is a potent inhibitor of nuclear factor-kappaB (NF-kappaB), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. , 2004, International immunopharmacology.

[43]  Tomohiro Sawa,et al.  Chemical basis of inflammation-induced carcinogenesis. , 2003, Archives of biochemistry and biophysics.

[44]  E. El-Omar,et al.  The role of interleukin-1beta and other potential genetic markers as indicators of gastric cancer risk. , 2003, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[45]  W. Herzog,et al.  IL‐1β induces COX2, MMP‐1, ‐3 and ‐13, ADAMTS‐4, IL‐1β and IL‐6 in human tendon cells , 2003 .

[46]  Masaharu Akiyama,et al.  Targeting p38 MAPK inhibits multiple myeloma cell growth in the bone marrow milieu. , 2003, Blood.

[47]  G. Johnson,et al.  Mitogen-Activated Protein Kinase Pathways Mediated by ERK, JNK, and p38 Protein Kinases , 2002, Science.

[48]  Jiahuai Han,et al.  MAPKK-Independent Activation of p38α Mediated by TAB1-Dependent Autophosphorylation of p38α , 2002, Science.

[49]  D. Thuerauf,et al.  p38 MAPK and NF-kappa B collaborate to induce interleukin-6 gene expression and release. Evidence for a cytoprotective autocrine signaling pathway in a cardiac myocyte model system. , 2000, The Journal of biological chemistry.

[50]  T. Hirano,et al.  Roles of STAT3 in mediating the cell growth, differentiation and survival signals relayed through the IL-6 family of cytokine receptors , 2000, Oncogene.

[51]  M. Yaffe,et al.  MAP kinase pathways activated by stress: the p38 MAPK pathway. , 2000, Critical care medicine.

[52]  J. Baldassare,et al.  The role of p38 mitogen-activated protein kinase in IL-1 beta transcription. , 1999, Journal of immunology.

[53]  J FusterObregón,et al.  Treatment of gastric cancer , 1999 .

[54]  E. Krebs,et al.  The MAPK signaling cascade , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[55]  J. Voltas,et al.  [Treatment of gastric cancer]. , 1982, Revista de medicina de la Universidad de Navarra.